PLoS ONE, 2022 · DOI: https://doi.org/10.1371/journal.pone.0262755 · Published: January 27, 2022
Chronic spinal cord injury is a debilitating condition with limited treatment options. This study explores the potential of hair-follicle-associated pluripotent (HAP) stem cells to repair chronic SCI. HAP stem cells, encapsulated in membranes, were implanted into the severed spinal cords of mice in the early chronic phase of injury. The implanted HAP stem cells differentiated into neurons and other types of cells that are needed for spinal cord function. The study found that mice implanted with HAP stem cells showed significant functional improvement compared to non-implanted mice, suggesting that HAP stem cells have clinical potential for SCI repair.
HAP stem cells may offer a readily accessible and autologous source for cell-based therapies for chronic SCI, reducing the risk of immune rejection and teratoma formation.
The encapsulation of HAP stem cells in PFM provides a delivery method that supports cell survival, differentiation, and integration into the injured spinal cord.
Further studies are needed to optimize the implantation protocol, assess long-term safety and efficacy, and explore the potential of HAP stem cells in combination with other therapeutic strategies for SCI.